Sustained low-efficiency dialysis for metformin-associated lactic acidosis in patients with acute kidney injury
- 145 Downloads
The choice of the specific modality and treatment duration of renal replacement therapy (RRT) to adopt in metformin-associated lactic acidosis (MALA) is still debated. We aimed to verify if sustained low-efficiency dialysis (SLED) is a rational choice in patients with MALA and acute kidney injury (AKI).
We collected serial serum metformin measurements, clinical parameters, and outcome data in ten consecutive patients (mean age 77 years [range 58–88], 5 males) admitted to our renal intensive care unit for suspected MALA associated with AKI and hemodynamic instability. Patients underwent a 16-h SLED session performed with either conventional dialysis machines or machines for continuous RRT (CRRT). A 2-compartment open-infusion pharmacokinetic model with first-order elimination was fitted to each subject’s serum concentration–time data to model post-SLED rebound and predict the need for further treatments.
Two patients died within 24 h after SLED start. Three patients needed one further dialysis session. Surviving patients (n = 8) were dialysis-free at discharge. Metformin levels were in the toxic range at baseline (median [range] 32.5 mg/l [13.6–75.6]) and decreased rapidly by the end of SLED (8.1 mg/l [4.5–15.8], p < 0.001 vs. baseline), without differences according to the dialysis machine used (p = 0.84). We observed a slight 4-h post-SLED rebound (9.7 mg/l [3.5–22.0]), which could be predicted by our pharmacokinetic model. Accordingly, we predicted that the majority of patients would need one additional dialysis session performed the following day to restore safe metformin levels.
A 16-h SLED session, performed with either conventional dialysis machines or CRRT machines, allows effective metformin removal in patients with MALA and AKI. However, due to possible post-SLED rebound in serum metformin levels, one additional dialysis treatment is required the following day in the majority of patients.
KeywordsMetformin Lactic acidosis Acute kidney injury Sustained low-efficiency dialysis Pharmacokinetics
Research idea and study design: PG, GR, UM, EnFi; data acquisition: PG, ElFe, FF, EP, CM, IG; data analysis/interpretation: UM, GR, PG; statistical analysis: UM, GR; supervision and mentorship: EnFi, GR. Each author contributed important intellectual content during manuscript drafting or revision and accepts accountability for the overall work by ensuring that questions pertaining to the accuracy or integrity of any portion of the work are appropriately investigated and resolved.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in this study, involving human participants, were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent was obtained from all individual participants included in the study.
- 1.Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M et al (2015) Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 38:140–149CrossRefGoogle Scholar
- 2.Garber AJ, Abrahamson MJ, Barzilay JI, Blonde L, Bloomgarden ZT, Bush MA et al (2016) Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm. 2016 Executive summary. Endocr Pract 22:84–113CrossRefGoogle Scholar
- 13.D’Argenio DZ, Schumitzky A (1997) Adapt II release 4, user’s guide. In: Biomedical simulations resource. University of Southern California, Los AngelesGoogle Scholar
- 20.Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2013) KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int 84(3):1–150Google Scholar
- 21.National Institute for Health and Care Excellence. NICE guidelines [NG28] (2015) Type 2 diabetes in adults: management. https://www.nice.org.uk/guidance/NG28/chapter/1-Recommendations. Accessed 24 Nov 2017 (Published date: December 2015. Last updated: May 2017)
- 24.Lalau JD, Andrejak M, Morinière P, Coevoet B, Debussche X, Westeel PF et al (1989) Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination. Int Clin Pharmacol Ther Toxicol 27:285–288Google Scholar
- 30.Teutonico A, Libutti P, Lomonte C, Antonelli M, Casucci F, Basile C (2008) Treatment of metformin-associated lactic acidosis with sustained low-efficiency daily dialysis. NDT Plus 1:380–381Google Scholar